River Stone uses synthetic biology to enable new pharmaceutical approaches.
We are focused on three areas
IN SITU
Making small molecule APIs inside the body. Enables entirely new ways of treating disease
READ MORE
PIONEERING SYNTHETIC BIOLOGY
River Stone was founded in 2016 with a focus on API production route re-engineering. Our team has a track record in building pioneering synthetic biology and life science ventures. The team has brought multiple synbio and pharma products to market.
READ MORE
SENIOR TEAM





